X0306 4 2021-06-14 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001810406 Bjork Elisabeth C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true Stock Option (Right to Buy) 47.25 2021-06-14 4 A 0 12236 0 A 2031-06-14 Common Stock 12236 12236 D Stock Option (Right to Buy) 47.25 2021-06-14 4 A 0 1699 29.42 A 2031-06-14 Common Stock 1699 1699 D This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option represents a right to purchase a total of 1,699 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000. /s/ Sara Turken, as attorney-in-fact 2021-06-16